To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • FAQs

    Cell Isolation/Cell Separation Market size was valued at USD 9.98 Billion in 2024 and is poised to grow from USD 11.01 Billion in 2025 to USD 24.12 Billion by 2033, growing at a CAGR of 10.3% during the forecast period (2026–2033).

    Global Cell Isolation/Cell Separation Market is competitive and fragmented. Key players include Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Danaher, Beckman Coulter, Inc. and Cytiva. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. 'Terumo Corporation', 'STEMCELL Technologies Inc. ', 'Bio-Rad Laboratories, Inc. ', 'Merck KGaA ', 'GE Healthcare ', 'Miltenyi Biotec ', 'pluriSelect Life Science UG & Co. KG ', 'Takara Bio Inc ', 'EMD Millipore ', 'PerkinElmer ', 'ZEISS ', 'Akadeum Life Sciences'

    The primary driver for market expansion is the rise in number of cancer infected patients. The market is also anticipated to develop as a result of rise in government support for cell-based research, and a growing emphasis on customised treatment, and technical advancements. 

    Growing use of microfluidic technologies: The use of microfluidic technologies offers a better control for cell flows and fluids resulting in an effective cell separation.

    North America accounted for a large market share in 2022. This can be ascribed to the developed pharmaceutical and biotech sectors as well as the widespread use of innovative technology in the United States. There is a big market for cell separation technologies as a result of research universities' extensive activity in the field of cell treatments. Additionally, the growing incidence of chronic and infectious disorders, has increased the need for cell separation technologies for use in both research and therapeutic settings.

    Feedback From Our Clients

    Global Cell Isolation/Cell Separation Market

    Report ID: SQMIG35H2169

    $5,300
    BUY NOW